Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Disease area: Airway diseases

Abstract

Exhaled breath condensate (EBC) reflects the composition of the airway-lining fluid and may contain biomarkers of diseases of respiratory system.
The aim of this study is to identify proteins in EBC of patients with chronic obstructive pulmonary disease (COPD) and pneumonia using two techniques of proteome identification.
Seventeen COPD and thirteen pneumonia samples were collected using the Jaeger ECoScreen (VIASYS Healthcare, Germany), freeze dried, treated with trypsin and analyzed by nanoflow LC-MS/MS with a 7-Tesla Finnigan LTQ-FT mass spectrometer (Thermo Electron, Germany). Six COPD samples were mixed and applied to 2D-PAAGE by Mini-PROTEAN system (Bio-RAD, USA). Silver stained spots were analyzed by MALDI-TOF-MS using a Microflex device (Bruker Daltonics, Germany).
Using 2D-PAAGE and MALDI-TOF-MS we were able to show that EBC samples from patients with COPD contain whole "normal" keratins that were detected also in EBC of healthy donors.
Using LC-MS/MS, a method of comparable sensitivity, specific peptides of "abnormal" keratins 3, 4, 8 were identified in COPD samples. Keratin set identified in samples from patients with acute pneumonia was more varied.
Peptides of Plakoglobin, Desmoplakin, Alpha-1-acid glycoprotein, Filaggrin, Dynein, Collagen, Hornerin were discovered in COPD and pneumonia EBC samples. They are uncharacteristic of healthy EBC samples. None of these proteins was identified as a whole in 2D-PAA gels. These peptides seem to appear in airway-lining fluid due to proteolysis in respiratory tract tissue.
In conclusion, each of "abnormal" peptides, as well as their combinations, may have diagnostic value.

Rating:

Share or cite this content

Citations should be made in the following way:
A. Ryabokon, V. Kurova, E. Anaev, A. Kononikhin, K. Fedorchenko, E. Nikolaev, S. Varfolomeev (Moscow, Russian Federation). Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry. Eur Respir J 2011; 38: Suppl. 55, 4792

Member's Comments

No comment yet.

Related content which might interest you: The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Human skin keratins are the major proteins in exhaled breath condensate Source: Eur Respir J 2008; 31: 380-384 Year: 2008 Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012 Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Detection of infectious agents in the airways by ion mobility spectrometry in exhaled breath Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Differentialion mobility spectrometry (DMS) for discrimination of local gut infection in exhaled breath Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 How to measure exhaled breath MDA in normal subjects: assessment of two ionisation modes used by LC-MS/MS. Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008 Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006 Analysis of exhaled breath condensate proteom and BAL Proteom by matrix assisted laser desorption/ioniosation – time of flight (MALDI-TOF) from patients with acute lung injury Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside Year: 2003 Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Proteins in exhaled breath condensate: identification and pattern Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Liquid chromatography-mass spectrometry (LC/MS) detects biomarker proteins in exhaled breath condensate (EBC) from endotracheally intubated patients collected at the exhaust port of a ventilator Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006 Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003 Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009